Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump By: Benzinga via Benzinga June 11, 2014 at 11:24 AM EDT Orexigen Therapeutics (NASDAQ: OREX) on Tuesday announced that the FDA has issued a three-month extension for the review of ... Read More >> Related Stocks: Vivus Inc